3 ms·
Here's a nice profile from the New Yorker in late 2014: http://www.newyorker.com/magazine/2014/12/15/blood-simpler http://www.newyorker.com/magazine/2014/12/15
by danso 11y ago
Here's a nice profile from the New Yorker in late 2014:
http://www.newyorker.com/magazine/2014/12/15/blood-simpler http://www.newyorker.com/magazine/2014/12/15/blood-simpler
I mean "nice" as in, a good read...it's a flattering profile of Holmes -- she comes off well, as a genuinely passionate person, and even if she had stayed in school, it sounds like she would've still made a great impact.
But the article also raises concerns that seem to be corroborated by the OP:
> Clarke argues that finger-stick blood tests aren’t reliable for clinical diagnostic tests; because the blood isn’t drawn from a vein, the sample can be contaminated by lanced capillaries or damaged tissue. Holmes strongly disagrees: “We have data that show you can get a perfect correlation between a finger stick and a venipuncture for every test that we run.” When I asked for evidence, I was sent a document by Daniel P. Edlin, Theranos’s senior product manager, titled “Select Data.” It purported to show favorable results from numerous comparison tests. I asked Edlin if the tests had been conducted by an independent third party. He replied by e-mail: “The clinical tests were conducted by a combination of Theranos and external labs,” but he wouldn’t say which ones.
Um, OK. I don't know much about this testing process...but...what trade secrets are being protected by hiding the methodology and source of the comparative test results?
- dbcooper 11y agoI was helping a friend design a microfluidic device for platelet characterisation, and the first thing he told me was that only a vein was suitable for drawing blood for platelets. He had to take a phlebotomy course just for the blood for testing prototypes.